CClinicalTrials.gg
CompletedNCT01138280Updated Jun 7, 2010

Heat Disinfection of HD Water Treatment System in Hemodialysis Patients

A Phase 4 interventional study of CWP 103H (Gambro, Sweden): a heat disinfection device in All Cause Mortality, sponsored by Taipei Veterans General Hospital, Taiwan. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2010-06-07.

Sponsored by Taipei Veterans General Hospital, Taiwan · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
540
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

Hemodialysis (HD) may lead to increase inflammatory response through a number of mechanisms. HD-related inflammation is mainly due to underlying kidney disease, coexisting comorbidities, uremia per se, dialyzer membrane biocompatibility and contaminated dialysis fluid. Accordingly, HD patients are chronically exposed to microinflammation as a result of blood-membrane interaction and dialysis fluid contamination. Among these factors, biofilm formation and contaminated dialysis fluid are closely related to enhanced immune activation in HD patients. Furthermore, only dialysis fluid quality is controllable and preventable. Therefore, to reduce the cardiovascular (CV) events and improve the outcome, it prompts us to conduct a prospective randomized controlled study to explore whether heat disinfection link in HD water treatment system can effectively prevent biofilm formation, to ensure the dialysis fluid purity, and subsequently to improve the patient outcome, in terms of CV events and mortality.

Read the detailed description

Inflammation is common in individuals with both chronic kidney disease (CKD) and hemodialysis (HD). HD may lead to increased inflammatory response through a number of mechanisms; some of these factors also result in pro-inflammatory cytokine release and consequently cause the overlap between anemia, accelerated atherosclerosis and inflammation. HD-related inflammation is mainly due to underlying kidney disease, coexisting comorbidities, uremia per se, dialyzer membrane biocompatibility and contaminated dialysis fluid. Accordingly, HD patients are chronically exposed to microinflammation as a result of blood-membrane interaction and dialysis fluid contamination. Among these factors, biofilm formation and contaminated dialysis fluid are closely related to enhanced immune activation in HD patients. Furthermore, only dialysis fluid quality is controllable and preventable. Therefore, to correct rHuEPO poor response and reduce the cardiovascular (CV) events, it prompts us to conduct a prospective randomized controlled study to explore as to whether heat disinfection link in HD water treatment system can effectively prevent biofilm formation, to ensure the dialysis fluid purity, and subsequently to improve the patient outcome, in terms of CV events and mortality.

02

Conditions studied

  • All Cause Mortality

Keywords

  • biofilm formation
  • proinflammatory cytokines
  • high sensitive c reactive protein
  • cardiovascular events
  • overall mortality
  • hemodialysis
03

In context

Lead sponsor

Taipei Veterans General Hospital, Taiwan is the lead sponsor of 325 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age over 20 years and duration of HD over 3 months, and clinically stable

Exclusion criteria

Exclusion Criteria:

  • patients with acute infection, malignancy, active autoimmune disease, GI bleeding or blood loss; systemic inflammatory disease; life expectancy less than 3 months, and unwilling to participate in this study.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
540 participants (actual)

Study arms

  • Experimental
    Heat disinfection

    Experimental arm: Heat disinfection link to RO water treatment system and piping system to dialysis machine

    Device: CWP 103H (Gambro, Sweden): a heat disinfection device

  • No intervention
    Conventional RO water treatment

    Placebo arm: conventional chemical disinfection link to RO water treatment system.

Interventions

  • DeviceCWP 103H (Gambro, Sweden): a heat disinfection device

    Heat disinfection can increase temperature to 95c in the RO water treatment system and then in the piping system link to dialysis machines in each hemodialysis center per night

    Also known as: Heat disinfection (temperature up to 95 c), RO water treatment system, piping system, dialysis machine

06

What researchers measure

Primary outcomes

  1. CV events, CV

    Time frame: 5 years

  2. all-cause mortality

    Time frame: 5 years

Secondary outcomes

  1. biofilm formation

    Time frame: 5 years

  2. endotoxin level of dialysis water

    Time frame: 5 years

  3. pro-inflammatory cytokine levels in serum

    Time frame: 5 years

07

Study locations

1 site
  • Taipei Veterans General Hospital
    Taipei, 11217, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01138280
Lead sponsor
Taipei Veterans General Hospital, Taiwan
Collaborators
National Science Council, Taiwan
First posted
Jun 7, 2010
Start date
Mar 2005
Primary completion
Dec 2009
Completion
Mar 2010
Last update
Jun 7, 2010

Study contacts

Der-Cherng Tarng, MD, PhD
principal investigator · Taipei Veterans General Hospital, Taiwan

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion